|
1.
|
Vose J and Armitage J: and Weisenburger.
International T-Cell Lymphoma Project: International peripheral
T-cell and natural killer/T-cell lymphoma study: Pathology findings
and clinical outcomes. J Clin Oncol. 26:4124–4130. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
2.
|
Federico M, Rudiger T, Bellei M, Nathwani
BN, Luminari S, Coiffier B, Harris NL, Jaffe ES, Pileri SA, Savage
KJ, et al: Clinicopathologic characteristics of angioimmunoblastic
T-cell lymphoma: Analysis of the international peripheral T-cell
lymphoma project. J Clin Oncol. 31:240–246. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3.
|
Lunning MA, Moskowitz AJ and Horwitz S:
Strategies for relapsed peripheral T-cell lymphoma: The tail that
wags the curve. J Clin Oncol. 31:1922–1927. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4.
|
Schmitz N, Trümper L, Ziepert M, Nickelsen
M, Ho AD, Metzner B, Peter N, Loeffler M, Rosenwald A and
Pfreundschuh M: Treatment and prognosis of mature T-cell and
NK-cell lymphoma: An analysis of patients with T-cell lymphoma
treated in studies of the German High-Grade Non-Hodgkin Lymphoma
Study Group. Blood. 116:3418–3425. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5.
|
Rodríguez J, Conde E, Gutiérrez A, Arranz
R, León A, Marín J, Bendandi M, Albo C and Caballero MD: The
results of consolidation with autologous stem-cell transplantation
in patients with peripheral T-cell lymphoma (PTCL) in first
complete remission: The Spanish Lymphoma and Autologous
Transplantation Group experience. Ann Oncol. 18:652–657. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
6.
|
Feyler S, Prince HM, Pearce R, Towlson K,
Nivison-Smith I, Schey S, Gibson J, Patton N, Bradstock K, Marks DI
and Cook G: The role of high-dose therapy and stem cell rescue in
the management of T-cell malignant lymphomas: A BSBMT and ABMTRR
study. Bone Marrow Transplant. 40:443–450. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7.
|
Moskowitz AJ, Lunning MA and Horwitz SM:
How I treat the peripheral T-cell lymphomas. Blood. 123:2636–2644.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
8.
|
Savage KJ, Chhanabhai M, Gascoyne RD and
Connors JM: Characterization of peripheral T-cell lymphomas in a
single North American institution by the WHO classification. Ann
Oncol. 15:1467–1475. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
9.
|
Escalón MP, Liu NS, Yang Y, Hess M, Walker
PL, Smith TL and Dang NH: Prognostic factors and treatment of
patients with T-cell non-Hodgkin lymphoma: The M. D. Anderson
Cancer Center experience. Cancer. 103:2091–2098. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10.
|
Barbarotta L and Hurley K: Romidepsin for
the treatment of peripheral T-cell lymphoma. J Adv Pract Oncol.
6:22–36. 2015.PubMed/NCBI
|
|
11.
|
Bekkenk MW, Vermeer MH, Jansen PM, van
Marion AM, Canninga-van Dijk MR, Kluin PM, Geerts ML, Meijer CJ and
Willemze R: Peripheral T-cell lymphomas unspecified presenting in
the skin: Analysis of prognostic factors in a group of 82 patients.
Blood. 102:2213–2219. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
12.
|
Lee HJ, Im JG, Goo JM, Kim KW, Choi BI,
Chang KH, Han JK and Han MH: Peripheral T-cell lymphoma: Spectrum
of imaging findings with clinical and pathologic features.
Radiographics. 23:7–26. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
13.
|
Salazar AJ, Aguirre DA, Ocampo J, Camacho
JC and Díaz XA: Evaluation of three pneumothorax size
quantification methods on digitized chest X-ray films using
medical-grade grayscale and consumer-grade color displays. J Digit
Imaging. 27:280–286. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14.
|
Luh SP: Review: Diagnosis and treatment of
primary spontaneous pneumothorax. J Zhejiang Univ Sci B.
11:735–744. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15.
|
Noppen M and de Keukeleire T:
Pneumothorax. Respiration. 76:121–127. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16.
|
Sahn SA and Heffner JE: Spontaneous
pneumothorax. N Engl J Med. 342:868–874. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
17.
|
Hobbs BD, Foreman MG, Bowler R, Jacobson
F, Make BJ, Castaldi PJ, San José, Estépar R, Silverman EK and
Hersh CP: COPDGene Investigators: Pneumothorax risk factors in
smokers with and without chronic obstructive pulmonary disease. Ann
Am Thorac Soc. 11:1387–1394. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18.
|
Schmidt-Horlohé N, Rudig L, Azvedo CT and
Habekost M: Fulminant unilateral pulmonary edema after insertion of
a chest tube: A complication after a primary spontaneous
pneumothorax. Dtsch Arztebl Int. 105:878–881. 2008.PubMed/NCBI
|
|
19.
|
Matano S, Satoh S, Sugiguchi S and
Sugimoto T: Pneumothorax associated with malignant lymphoma. Intern
Med. 49:2337–2339. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20.
|
Parissis H: Forty years literature review
of primary lung lymphoma. J Cardiothoracic Surg. 6:232011.
View Article : Google Scholar
|
|
21.
|
Cadranel J, Wislez M and Antoine M:
Primary pulmonary lymphoma. Eur Respir J. 20:750–762. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
22.
|
Niu X, Hu H, Gao J, Nie Y, Zhao W, Xu H,
Bai X and Chen L: A clinical analysis of 40 cases of primary and
secondary pulmonary lymphoma. Zhonghua Jie He He Hu Xi Za Zhi.
37:502–506. 2014.(In Chinese). PubMed/NCBI
|
|
23.
|
Zhu L and Zhang J: Pulmonary malignant
lymphoma: A clinicopathological analysis of 16 cases. J Diagn
Pathol. 20:740–743. 2013.
|
|
24.
|
Zhang ZY, Wu XH and Shi YX: CT study of
pulmonary lymphoma comparison with X-ray. Clin Med J China.
8:26–28. 2001.
|
|
25.
|
Hare SS, Souza CA, Bain G, Seely JM Frcpc,
Gomes MM and Quigley M: The radiological spectrum of pulmonary
lymphoproliferative disease. Br J Radiol. 85:848–864. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
26.
|
Shan Y and Zhou Y: Recent research of
pathogenesis and causes of recurrence of primary spontaneous
pneumothorax. Surg Res New Technique. 4:52–56. 2015.
|
|
27.
|
Went P, Agostinelli C, Gallamini A,
Piccaluga PP, Ascani S, Sabattini E, Bacci F, Falini B, Motta T,
Paulli M, et al: Marker expression in peripheral T-cell lymphoma: A
proposed clinical-pathologic prognostic score. J Clin Oncol.
24:2472–2479. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
28.
|
Wang XY, Xia GG, Zhang YJ, Zhang B and
Zhang PJ: Angioimmunoblastic T-cell lymphoma: A case report and
review of literature. Int J Respir 32. 6:91–94. 2012.(In
Chinese).
|
|
29.
|
Zhe W, Xie YQ and Zhu J: The advance in
diagnosis and treatment of peripheral T-cell lymphoma-unspecified.
Chin J Clin Oncol. 33:476–480. 2006.
|
|
30.
|
Morabito F, Gallamini A, Stelitano C,
Callea V, Guglielmi C, Neri S, Lazzaro A, Orsucci L, Ilariucci F,
Sacchi S, et al: Clinical relevance of immunophenotype in a
retrospective comparative study of 297 peripheral T-cell lymphomas,
unspecified, and 496 diffuse large B-cell lymphomas: Experience of
the Intergruppo Italiano Linformi. Cancer. 101:1601–1608. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
31.
|
Intragumtornchai T, Rotnakkarin P,
Sutcharitchan P and Wannagrairoj P: Prognostic significance of the
immunophenotype versus the International Prognostic Index in
aggressive non-Hodgk'ns lymphoma. Clin Lymphoma. 4:52–55. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
32.
|
Gui L, Shi YK, He XH, Lei YH, Zhang HZ,
Han XH, Zhou SY, Liu P, Yang JL, Dong M, et al: High-dose therapy
and autologous stem cell transplantation in peripheral T-cell
lymphoma: Treatment outcome and prognostic factor analysis. Int J
Hematol. 99:69–78. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
33.
|
Hopfinger G, Nösslinger T, Lang A,
Linkesch W, Melchardt T, Weiss L, Egle A and Greil R: Lenalidomide
in combination with vorinostat and dexamethasone for the treatment
of relapsed/refractory peripheral T cell lymphoma (PTCL): Report of
a phase I/II trial. Ann Hematol. 93:459–462. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
34.
|
Evens AM, Rosen ST, Helenowski I, Kline J,
Larsen A, Colvin J, Winter JN, van Besien KM, Gordon LI and Smith
SM: A phase I/II trial of bortezomib combined concurrently with
gemcitabine for relapsed or refractory DLBCL and peripheral T-cell
lymphomas. Br J Haematol. 163:55–61. 2013. View Article : Google Scholar : PubMed/NCBI
|
